Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide vs Lamotrigine in Refractory Partial Seizures
NCT00292461Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2006
- Primary completion
- Aug 2009
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of zonisamide in epilepsy (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Percentage Change of Monthly Seizure Frequency at 16 weeks. Started Mar 2006; status: completed.
02
Drugs
zonisamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00292461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00292461.